{"the anticoagulant activities increase": 0, "The risk or severity of bleeding and hemorrhage increase": 1, "The risk or severity of bleeding increase": 2, "The therapeutic efficacy increase": 3, "the anticoagulant activities decrease": 4, "The therapeutic efficacy decrease": 5, "The risk or severity of hemorrhage increase": 6, "the antiplatelet activities increase": 7, "The risk or severity of adverse effects increase": 8, "The risk or severity of hyponatremia increase": 9, "the antihypertensive activities decrease": 10, "The risk or severity of hypertension increase": 11, "the excretion rate which could result in a higher serum level decrease": 12, "the excretion rate which could result in a lower serum level and potentially a reduction in efficacy increase": 13, "the hypertensive activities increase": 14, "the immunosuppressive activities increase": 15, "The serum concentration increase": 16, "the nephrotoxic activities increase": 17, "The excretion decrease": 18, "The serum concentration decrease": 19, "the neurotoxic activities increase": 20, "an increase in the absorption resulting in an increased serum concentration and potentially a worsening of adverse effects cause": 21, "The metabolism increase": 22, "The metabolism decrease": 23, "a decrease in the absorption resulting in a reduced serum concentration and potentially a decrease in efficacy cause": 24, "The risk or severity of myelosuppression increase": 25, "The risk or severity of renal failure increase": 26, "The risk or severity of hyperkalemia increase": 27, "The risk or severity of nephrotoxicity increase": 28, "The risk or severity of liver damage increase": 29, "The risk or severity of renal failure and hypertension increase": 30, "The risk or severity of myopathy rhabdomyolysis and myoglobinuria increase": 31, "The risk or severity of seizure increase": 32, "the hepatotoxic activities increase": 33, "The risk or severity of hypokalemia increase": 34, "the central nervous system depressant ( CNS depressant ) activities increase": 35, "the sedative activities increase": 36, "the serotonergic activities increase": 37, "The risk or severity of serotonin syndrome increase": 38, "The risk or severity of CNS depression increase": 39, "The risk or severity of sedation increase": 40, "The risk or severity of hypoglycemia increase": 41, "the thrombogenic activities increase": 42, "The risk or severity of neutropenia increase": 43, "The risk or severity of QTc prolongation increase": 44, "The risk or severity of gastrointestinal bleeding increase": 45, "The risk or severity of hypotension increase": 46, "The risk or severity of orthostatic hypotension and syncope increase": 47, "The risk or severity of hypotension and orthostatic hypotension increase": 48, "the hypotensive activities increase": 49, "the antihypertensive activities increase": 50, "The risk or severity of renal failure hyperkalemia and hypertension increase": 51, "The risk or severity of renal failure hypotension and hyperkalemia increase": 52, "the hyperkalemic activities increase": 53, "The risk or severity of angioedema increase": 54, "the orthostatic hypotensive activities increase": 55, "the neuromuscular blocking activities increase": 56, "the bradycardic activities increase": 57, "the neuromuscular blocking activities decrease": 58, "The risk or severity of hyperglycemia increase": 59, "The risk or severity of tendinopathy increase": 60, "the hypokalemic activities increase": 61, "The risk or severity of fluid retention increase": 62, "The risk or severity of gastrointestinal irritation increase": 63, "The risk or severity of myopathy and weakness increase": 64, "The risk or severity of edema formation increase": 65, "The risk or severity of electrolyte imbalance increase": 66, "the anticholinergic activities increase": 67, "the analgesic activities increase": 68, "the sedative and stimulatory activities decrease": 69, "the stimulatory activities decrease": 70, "the hypoglycemic activities increase": 71, "The risk or severity of Tachycardia increase": 72, "The risk or severity of extrapyramidal symptoms increase": 73, "The risk or severity of sedation and somnolence increase": 74, "The risk or severity of hypertension decrease": 75, "the vasoconstricting activities increase": 76, "the arrhythmogenic activities increase": 77, "The risk or severity of bradycardia increase": 78, "The risk or severity of QTc prolongation decrease": 79, "the QTcprolonging activities increase": 80, "The risk or severity of neutropenia and thrombocytopenia increase": 81, "The risk or severity of hyperthermia and oligohydrosis increase": 82, "the hypoglycemic activities decrease": 83, "The serum concentration of the active metabolites increase": 84, "The risk or severity of QTc prolongation and hypotension increase": 85, "The risk or severity of Cardiac Arrhythmia increase": 86, "The risk or severity of hypotension dyspepsia and headache increase": 87, "the vasodilatory activities increase": 88, "The risk or severity of Tachycardia and drowsiness increase": 89, "The absorption decrease": 90, "the vasopressor activities increase": 91, "the hypertensive and vasoconstricting activities increase": 92, "the tachycardic activities increase": 93, "the neuroexcitatory activities increase": 94, "The protein binding decrease": 95, "the orthostatic hypotensive hypotensive and antihypertensive activities increase": 96, "The risk or severity of methemoglobinemia increase": 97, "The risk or severity of hypotension and CNS depression increase": 98, "the bronchodilatory activities decrease": 99, "DRUGBANK::carrier::Compound:Gene": 100, "DRUGBANK::enzyme::Compound:Gene": 101, "DRUGBANK::target::Compound:Gene": 102, "Hetionet::CbG::Compound:Gene": 103, "Hetionet::CdG::Compound:Gene": 104, "Hetionet::CuG::Compound:Gene": 105}